TNXP

Tonix Pharmaceuticals Holding (TNXP)

About Tonix Pharmaceuticals Holding (TNXP)

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Details

Daily high

$20.24

Daily low

$19.21

Price at open

$19.30

52 Week High

$130.00

52 Week Low

$6.76

Market cap

231.3M

Dividend yield

0.00%

Volume

593,325

Avg. volume

844,124

P/E ratio

-.02

Tonix Pharmaceuticals Holding News